Stock Taper 
ORBIMED ADVISORS LLC
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Syndax Pharmaceuticals, Inc. | SNDX | 1.54M | $33.71M |
 Cogent Biosciences, Inc. | COGT | 1.68M | $65.07M |
 uniQure N.V. | QURE | 1.81M | $83.25M |
 BioCryst Pharmaceuticals, Inc. | BCRX | 1.85M | $18.52M |
 ORIC Pharmaceuticals, Inc. | ORIC | 2.02M | $21.82M |
 Arcutis Biotherapeutics, Inc. | ARQT | 2.04M | $53.54M |
 Mineralys Therapeutics, Inc. | MLYS | 2.11M | $56.94M |
 Protara Therapeutics, Inc. | TARA | 2.22M | $8.48M |
 Caris Life Sciences, Inc. | CAI | 2.81M | $50.02M |
 Odyssey Therapeutics, Inc. | ODTX | 3M | $56.15M |
 ArriVent BioPharma, Inc. | AVBP | 3.03M | $105.17M |
 Dyne Therapeutics, Inc. | DYN | 3.24M | $71.86M |
 Aura Biosciences, Inc. | AURA | 3.33M | $23.67M |
 Relmada Therapeutics, Inc. | RLMD | 3.63M | $25.13M |
 Enliven Therapeutics, Inc. | ELVN | 6.78M | $343.91M |
 Corvus Pharmaceuticals, Inc. | CRVS | 7.17M | $107.05M |
 ARS Pharmaceuticals, Inc. | SPRY | 8.29M | $66.39M |
 Edgewise Therapeutics, Inc. | EWTX | 15.52M | $630.52M |